1481. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
作者: Paul Oster.;Laurie Vaillant.;Erika Riva.;Brynn McMillan.;Christina Begka.;Caroline Truntzer.;Corentin Richard.;Marine M Leblond.;Meriem Messaoudene.;Elisavet Machremi.;Emeric Limagne.;Francois Ghiringhelli.;Bertrand Routy.;Gregory Verdeil.;Dominique Velin.
来源: Gut. 2022年71卷3期457-466页
In this study, we determined whether Helicobacter pylori (H. pylori) infection dampens the efficacy of cancer immunotherapies.
1482. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny.
作者: Jianpeng Sheng.;Junlei Zhang.;Lin Wang.;Vincent Tano.;Jianghui Tang.;Xun Wang.;Jiangchao Wu.;Jinyuan Song.;Yaxing Zhao.;Jingxia Rong.;Fei Cheng.;Jianfeng Wang.;Yinan Shen.;Liang Wen.;Junjun He.;Hui Zhang.;Taohong Li.;Qi Zhang.;Xueli Bai.;Zhimin Lu.;Tingbo Liang.
来源: Gut. 2022年71卷6期1176-1191页
Hepatocellular carcinoma (HCC) tumour microenvironment (TME) is highly complex with diverse cellular components organising into various functional units, cellular neighbourhoods (CNs). And we wanted to define CN of HCC while preserving the TME architecture, based on which, potential targets for novel immunotherapy could be identified.
1483. Hidden link in gut-joint axis: gut microbes promote rheumatoid arthritis at early stage by enhancing ascorbate degradation.
作者: Yan Zhao.;Mingyue Cheng.;Liang Zou.;Luxu Yin.;Chaofang Zhong.;Yuguo Zha.;Xue Zhu.;Lei Zhang.;Kang Ning.;Jinxiang Han.
来源: Gut. 2022年71卷5期1041-1043页 1485. Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium.
作者: Lochlan Fennell.;Alexandra Kane.;Cheng Liu.;Diane McKeone.;Gunter Hartel.;Chang Su.;Catherine Bond.;Mark Bettington.;Barbara Leggett.;Vicki Whitehall.
来源: Gut. 2022年71卷6期1127-1140页
Sessile serrated lesions (SSLs) are common across the age spectrum, but the BRAF mutant cancers arising occur predominantly in the elderly. Aberrant DNA methylation is uncommon in SSL from young patients. Here, we interrogate the role of ageing and DNA methylation in SSL initiation and progression.
1486. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
作者: Devin Abrahami.;Emily Gibson McDonald.;Mireille E Schnitzer.;Alan N Barkun.;Samy Suissa.;Laurent Azoulay.
来源: Gut. 2022年71卷1期16-24页
To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs).
1487. Proton pump inhibitors and risk of colorectal cancer.
作者: Devin Abrahami.;Emily Gibson McDonald.;Mireille E Schnitzer.;Alan N Barkun.;Samy Suissa.;Laurent Azoulay.
来源: Gut. 2022年71卷1期111-118页
To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs).
1488. Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis.
作者: Jue-Sheng Ong.;Jiyuan An.;Xikun Han.;Matthew H Law.;Priyanka Nandakumar.; .; .;Johannes Schumacher.;Ines Gockel.;Anne Bohmer.;Janusz Jankowski.;Claire Palles.;Catherine M Olsen.;Rachel E Neale.;Rebecca Fitzgerald.;Aaron P Thrift.;Thomas L Vaughan.;Matthew F Buas.;David A Hinds.;Puya Gharahkhani.;Bradley J Kendall.;Stuart MacGregor.
来源: Gut. 2022年71卷6期1053-1061页
Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributable to its symptom-based definitions. GERD genome-wide association studies (GWASs) have shown strong genetic overlaps with established risk factors such as obesity and depression. We hypothesised that the shared genetic architecture between GERD and these risk factors can be leveraged to (1) identify new GERD and Barrett's oesophagus (BE) risk loci and (2) explore potentially heterogeneous pathways leading to GERD and oesophageal complications.
1489. Artificial intelligence and colonoscopy experience: lessons from two randomised trials.
作者: Alessandro Repici.;Marco Spadaccini.;Giulio Antonelli.;Loredana Correale.;Roberta Maselli.;Piera Alessia Galtieri.;Gaia Pellegatta.;Antonio Capogreco.;Sebastian Manuel Milluzzo.;Gianluca Lollo.;Dhanai Di Paolo.;Matteo Badalamenti.;Elisa Ferrara.;Alessandro Fugazza.;Silvia Carrara.;Andrea Anderloni.;Emanuele Rondonotti.;Arnaldo Amato.;Andrea De Gottardi.;Cristiano Spada.;Franco Radaelli.;Victor Savevski.;Michael B Wallace.;Prateek Sharma.;Thomas Rösch.;Cesare Hassan.
来源: Gut. 2022年71卷4期757-765页
Artificial intelligence has been shown to increase adenoma detection rate (ADR) as the main surrogate outcome parameter of colonoscopy quality. To which extent this effect may be related to physician experience is not known. We performed a randomised trial with colonoscopists in their qualification period (AID-2) and compared these data with a previously published randomised trial in expert endoscopists (AID-1).
1490. Identification of the source events for aerosol generation during oesophago-gastro-duodenoscopy.
作者: Florence K A Gregson.;Andrew J Shrimpton.;Fergus Hamilton.;Tim M Cook.;Jonathan P Reid.;Anthony E Pickering.;Dimitri J Pournaras.;Bryan R Bzdek.;Jules Brown.; .
来源: Gut. 2022年71卷5期871-878页
To determine if oesophago-gastro-duodenoscopy (OGD) generates increased levels of aerosol in conscious patients and identify the source events.
1491. Histopathological effects of electrosurgical interventions in an in vivo porcine model of colonic endoscopic mucosal resection.
作者: Anthony M Whitfield.;Nicholas G Burgess.;Farzan F Bahin.;Sharir Kabir.;María Pellisé.;Rebecca Sonson.;Vishnu Subramanian.;Hema Mahajan.;Duncan McLeod.;Karen Byth.;Michael J Bourke.
来源: Gut. 2022年71卷5期864-870页
Endoscopic mucosal resection (EMR) in the colon has been widely adopted, but there is limited data on the histopathological effects of the differing electrosurgical currents (ESCs) used. We used an in vivo porcine model to compare the tissue effects of ESCs for snare resection and adjuvant margin ablation techniques.
1493. Calprotectin: from biomarker to biological function.
作者: Almina Jukic.;Latifa Bakiri.;Erwin F Wagner.;Herbert Tilg.;Timon E Adolph.
来源: Gut. 2021年70卷10期1978-1988页
The incidence of inflammatory bowel diseases (IBD) emerged with Westernisation of dietary habits worldwide. Crohn's disease and ulcerative colitis are chronic debilitating conditions that afflict individuals with substantial morbidity and challenge healthcare systems across the globe. Since identification and characterisation of calprotectin (CP) in the 1980s, faecal CP emerged as significantly validated, non-invasive biomarker that allows evaluation of gut inflammation. Faecal CP discriminates between inflammatory and non-inflammatory diseases of the gut and portraits the disease course of human IBD. Recent studies revealed insights into biological functions of the CP subunits S100A8 and S100A9 during orchestration of an inflammatory response at mucosal surfaces across organ systems. In this review, we summarise longitudinal evidence for the evolution of CP from biomarker to rheostat of mucosal inflammation and suggest an algorithm for the interpretation of faecal CP in daily clinical practice. We propose that mechanistic insights into the biological function of CP in the gut and beyond may facilitate interpretation of current assays and guide patient-tailored medical therapy in IBD, a concept warranting controlled clinical trials.
1496. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies.
作者: Qibin Qi.;Jun Li.;Bing Yu.;Jee-Young Moon.;Jin C Chai.;Jordi Merino.;Jie Hu.;Miguel Ruiz-Canela.;Casey Rebholz.;Zheng Wang.;Mykhaylo Usyk.;Guo-Chong Chen.;Bianca C Porneala.;Wenshuang Wang.;Ngoc Quynh Nguyen.;Elena V Feofanova.;Megan L Grove.;Thomas J Wang.;Robert E Gerszten.;Josée Dupuis.;Jordi Salas-Salvadó.;Wei Bao.;David L Perkins.;Martha L Daviglus.;Bharat Thyagarajan.;Jianwen Cai.;Tao Wang.;JoAnn E Manson.;Miguel A Martínez-González.;Elizabeth Selvin.;Kathryn M Rexrode.;Clary B Clish.;Frank B Hu.;James B Meigs.;Rob Knight.;Robert D Burk.;Eric Boerwinkle.;Robert C Kaplan.
来源: Gut. 2022年71卷6期1095-1105页
Tryptophan can be catabolised to various metabolites through host kynurenine and microbial indole pathways. We aimed to examine relationships of host and microbial tryptophan metabolites with incident type 2 diabetes (T2D), host genetics, diet and gut microbiota.
1499. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice.
作者: Tiphaine Le Roy.;Emilie Moens de Hase.;Matthias Van Hul.;Adrien Paquot.;Rudy Pelicaen.;Marion Régnier.;Clara Depommier.;Céline Druart.;Amandine Everard.;Dominique Maiter.;Nathalie M Delzenne.;Laure B Bindels.;Marie de Barsy.;Audrey Loumaye.;Michel P Hermans.;Jean-Paul Thissen.;Sara Vieira-Silva.;Gwen Falony.;Jeroen Raes.;Giulio G Muccioli.;Patrice D Cani.
来源: Gut. 2022年71卷3期534-543页
To investigate the abundance and the prevalence of Dysosmobacter welbionis J115T, a novel butyrate-producing bacterium isolated from the human gut both in the general population and in subjects with metabolic syndrome. To study the impact of this bacterium on host metabolism using diet-induced obese and diabetic mice.
1500. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.
作者: Noel Pin-Vieito.;Coral Tejido-Sandoval.;Natalia de Vicente-Bielza.;Cristina Sánchez-Gómez.;Joaquín Cubiella.
来源: Gut. 2022年71卷5期950-960页
Implementation of faecal immunochemical tests (FIT) as a triage test in primary healthcare may improve the efficiency of referrals without missing cases of colorectal cancer (CRC). We aim to summarise the performance characteristics of FITs for CRC in symptomatic patients presenting to primary healthcare.
|